Statistics
Publications
15
Citations
7.8K
H-Index
14
Active since
2006
Andrew M. Rogers is an author at Harvard University specializing in medicine, oncology, and molecular oncology.
Publications per year
2006–2018
15
15
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke, Kreshnik Zejnullahu, Yi‐Long Wu et al. · Cancer Cell · 2010 · 1.1K citations · Full text
Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
Dalia Ercan, Chunxiao Xu, Masahiko Yanagita et al. · Cancer Discovery · 2012 · 291 citations · Full text
Medicine, Oncology, Pharmacology +17
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
Dalia Ercan, Kreshnik Zejnullahu, Kimio Yonesaka et al. · Oncogene · 2010 · 227 citations · Full text
1–5 of 15